Cargando…

Evolving treatment modalities for immune thrombocytopenia in adults

The management of patients with relapsed or refractory immune thrombocytopenia (ITP) remains challenging for hematologists. While there are a multitude of drugs available, it is largely an individualized management based on patient preferences, side effects, previous treatment received, and response...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khadka, Sushmita, Kasireddy, Vineela, Dhakal, Pravash Kumar, Dadiboyina, Chandrakala
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850435/ https://www.ncbi.nlm.nih.gov/pubmed/33552432 http://dx.doi.org/10.1080/20009666.2020.1843237

Ejemplares similares

Institutional Experience of Using Andexanet Alfa
por: Khadka, Sushmita, et al.
Publicado: (2020)

A Rare Presentation of an Invasive Ductal Carcinoma of Ectopic Axillary Breast Tissue
por: Mandal, Shobha, et al.
Publicado: (2020)

COVID-19 Presenting With a Challenging Combination of Thrombocytopenia and Thrombosis
por: Ravi, Swapna, et al.
Publicado: (2022)

Current and evolving treatment strategies in adult immune thrombocytopenia
por: Bohn, Jan-Paul, et al.
Publicado: (2018)

Aortitis in COVID-19
por: Dhakal, Pravash, et al.
Publicado: (2021)

A Case Report on Adenosquamous Carcinoma of Gallbladder: A Very Rare Malignancy
por: Mandal, Shobha, et al.
Publicado: (2021)

Transarterial Therapy: An Evolving Treatment Modality of Hepatocellular Carcinoma
por: Jazieh, Khalid A., et al.
Publicado: (2014)

Recent advances in treatments of adult immune thrombocytopenia
por: Kim, Dae Sik
Publicado: (2022)

Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease
por: Cheloff, Abraham Z, et al.
Publicado: (2019)

Adenosquamous Carcinoma of the Breast: Case Report and Literature Review
por: Priyadarshini, Shista, et al.
Publicado: (2022)

Celiac Disease Masquerading as Arthralgia
por: Priyadarshini, Shista, et al.
Publicado: (2022)

Older Adults and Immune Thrombocytopenia: Considerations for the Clinician
por: Crickx, Etienne, et al.
Publicado: (2023)

Advances in Diagnosis and Treatments for Immune Thrombocytopenia
por: Nomura, Shosaku
Publicado: (2016)

Treatment of drug-induced immune thrombocytopenias
por: Marini, Irene, et al.
Publicado: (2022)

How we treat primary immune thrombocytopenia in adults
por: Liu, Xin-guang, et al.
Publicado: (2023)

Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments
por: Audia, Sylvain, et al.
Publicado: (2021)

Recent advances in the mechanisms and treatment of immune thrombocytopenia
por: Provan, Drew, et al.
Publicado: (2022)

Efgartigimod alfa for the treatment of primary immune thrombocytopenia
por: Broome, Catherine
Publicado: (2023)

Corticosteroid overuse in adults with immune thrombocytopenia: Cause for concern
por: Cuker, Adam, et al.
Publicado: (2021)

Biomarkers for immune thrombocytopenia
por: Yu, Lingjia, et al.
Publicado: (2015)

Hyperprogression: A Unique Phenomenon of Progression of Existing Tumor Secondary to Immunotherapy
por: Mandal, Shobha, et al.
Publicado: (2021)

Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia
por: Cheung, Eric, et al.
Publicado: (2009)

Romiplostim as a treatment for immune thrombocytopenia: a review
por: Chalmers, Sarah, et al.
Publicado: (2015)

Spotlight on eltrombopag in the treatment of children with chronic immune thrombocytopenia
por: Lambert, Michele P
Publicado: (2016)

Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia
por: Janssens, Ann, et al.
Publicado: (2016)

T cell immune abnormalities in immune thrombocytopenia
por: Ji, Xuebin, et al.
Publicado: (2014)

Systematic literature review of treatments used for adult immune thrombocytopenia in the second‐line setting
por: Bylsma, Lauren C., et al.
Publicado: (2018)

Emerging Therapies in Immune Thrombocytopenia
por: Audia, Sylvain, et al.
Publicado: (2021)

A perspective on the diagnosis of cracked tooth: imaging modalities evolve to AI-based analysis
por: Guo, Juncheng, et al.
Publicado: (2022)

Long-term safety and efficacy of romiplostim for treatment of immune thrombocytopenia
por: Vishnu, Prakash, et al.
Publicado: (2016)

Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and Perspectives
por: Tsykunova, Galina, et al.
Publicado: (2022)

Evolving Concepts: Immunity in Oncology from Targets to Treatments
por: Khan, Hina, et al.
Publicado: (2015)

Thyrotoxic Periodic Paralysis with Hypokalemia in an Adult Male from Nepal: A Case Report
por: Khadka, Sabina, et al.
Publicado: (2019)

Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection
por: Dahal, Sumit, et al.
Publicado: (2017)

Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?
por: Lucchini, Elisa, et al.
Publicado: (2019)

Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand
por: Choi, Philip YI, et al.
Publicado: (2021)

Current Management of Primary Immune Thrombocytopenia
por: Provan, Drew, et al.
Publicado: (2015)

The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
por: Leone, Patrizia, et al.
Publicado: (2021)

Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia
por: Datta, Payel, et al.
Publicado: (2021)

Imbalance of T Lymphocyte Subsets in Adult Immune Thrombocytopenia
por: Lin, Xiuxiu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ngr721grclvvp2tsjbnihpc0t4